Company / Assets per Share
Moleculin Biotech, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$163.71
FY2025
5-year range
$7.29 / $163.71
FY2021-FY2025
Trend
+2054.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share changed +2055% YoY in FY2025, a notable deviation from the 8-year average annual change of +314%.
Based on SEC 10-K filings.
163.71 in FY2025 with a 5-year CAGR of +112.2%.
Improved from $20.02 to $163.71 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +112.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 2054.6% year-over-year.
- Lowest assets per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $163.71 | +2054.6% |
| FY2024 | $7.60 | -62.1% |
| FY2023 | $20.02 | - |
| FY2022 | - | - |
| FY2021 | $7.29 | +91.4% |
| FY2020 | $3.81 | +330.6% |
| FY2019 | $0.88 | -3.0% |
| FY2018 | $0.91 | -43.0% |
| FY2017 | $1.60 | -34.9% |
| FY2016 | $2.46 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026